Proteomics: a different lens for precision medicine
The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way
SCIENCE & TECHNOLOGY2024
perspectivesscience-technology
Filling the skills gap to advance genomic medicine: an interview with Emily Perry
By upskilling researchers on bioinformatics skills and tools, EMBL alumna Emily Perry is helping to make genomic medicine more accessible.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesperspectives
Genomic medicine: ushering in a new era in healthcare
EMBL-EBI data resources are being used to deliver thousands of genetic diagnostics to patients every month.
SCIENCE & TECHNOLOGY2023
perspectivessciencescience-technology
ERC Proof-of-Concept grant provides way to realise commercial potential of ‘SpaceM’ technology
A new grant will provide a way for fundamental metabolomic research to realise its commercial potential and promise in aiding drug development and precision medicine.
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-mattersscience-technology
When ‘good’ cells go ‘bad’
If researchers can identify specifically when good cells go bad, they can potentially understand disease better.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Charting a multi-omic universe
A research collaboration used machine learning to map tumour molecular make-up, potentially paving way to more customised cancer treatment.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
From mRNA researcher to BioNTech manager
EMBL alumnus Pawel Masiewicz has transferred skills and experience gained at EMBL to oversee starting materials for mRNA vaccine development.
PEOPLE & PERSPECTIVES2021
alumnipeople-perspectives
Achieving personalised therapeutics
A decadal roadmap points the way to cell-based medicine for Europe
LAB MATTERSSCIENCE & TECHNOLOGY2020
lab-mattersscience-technology
No results found